These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19617825)

  • 21. Contemporary lung transplantation: the UCLA experience.
    Sherman W; Rabkin D; Ross D; Ardehali A;
    Clin Transpl; 2008; ():163-70. PubMed ID: 19708455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart-lung transplantation: an overview.
    Starnes VA
    Cardiol Clin; 1990 Feb; 8(1):159-68. PubMed ID: 2407357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.
    Stewart S; Fishbein MC; Snell GI; Berry GJ; Boehler A; Burke MM; Glanville A; Gould FK; Magro C; Marboe CC; McNeil KD; Reed EF; Reinsmoen NL; Scott JP; Studer SM; Tazelaar HD; Wallwork JL; Westall G; Zamora MR; Zeevi A; Yousem SA
    J Heart Lung Transplant; 2007 Dec; 26(12):1229-42. PubMed ID: 18096473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation.
    Chamberlain D; Maurer J; Chaparro C; Idolor L
    J Heart Lung Transplant; 1994; 13(6):963-71. PubMed ID: 7865530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart-lung transplantation].
    Sleiman C; Groussard O; Mal H; Fournier M
    Rev Mal Respir; 1996 Nov; 13(5 Suppl):S31-40. PubMed ID: 9011909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Graft immunity in lung transplantation].
    Mornex JF
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):257-66. PubMed ID: 12844023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major medical complications of lung transplantation: a pediatric perspective.
    Mallory GB
    Semin Thorac Cardiovasc Surg; 1996 Jul; 8(3):305-12. PubMed ID: 8843523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical care aspects of lung transplantation.
    Lau CL; Patterson GA; Palmer SM
    J Intensive Care Med; 2004; 19(2):83-104. PubMed ID: 15070519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
    Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic allograft rejection (obliterative bronchiolitis).
    Verleden GM
    Semin Respir Crit Care Med; 2001 Oct; 22(5):551-8. PubMed ID: 16088701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung transplantation: a decade of experience.
    Moffatt SD; Demers P; Robbins RC; Doyle R; Wienacker A; Henig N; Theodore J; Reitz BA; Whyte RI
    J Heart Lung Transplant; 2005 Feb; 24(2):145-51. PubMed ID: 15701428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased lung allograft failure in patients with HLA-specific antibody.
    Girnita AL; McCurry KR; Zeevi A
    Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.
    Cooper JD; Billingham M; Egan T; Hertz MI; Higenbottam T; Lynch J; Mauer J; Paradis I; Patterson GA; Smith C
    J Heart Lung Transplant; 1993; 12(5):713-6. PubMed ID: 8241207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.